治疗方法：成功组合。 - Suppr

Suppr

超能文献

Therapeutics: Winning combination.

作者信息

Villanueva M Teresa

出版信息

Nat Rev Cancer. 2015 Jan;15(1):2. doi: 10.1038/nrc3882.

DOI:10.1038/nrc3882

PMID:25533666

Abstract

摘要

相似文献

Therapeutics: Winning combination.治疗方法：成功组合。

Nat Rev Cancer. 2015 Jan;15(1):2. doi: 10.1038/nrc3882.

Anticancer drugs: Finding the perfect combination.抗癌药物：寻找完美组合。

Nat Rev Drug Discov. 2015 Jan;14(1):13. doi: 10.1038/nrd4524.

Personalized one-two punches for lung cancer.针对肺癌的个性化双重打击疗法。

Cell Res. 2015 Mar;25(3):269-70. doi: 10.1038/cr.2014.168. Epub 2014 Dec 30.

Consecutive Emergence of Typical Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in a Patient With Metastatic Pulmonary Squamous Cell Carcinoma.一名转移性肺鳞状细胞癌患者中连续出现对EGFR酪氨酸激酶抑制剂的典型获得性耐药

J Oncol Pract. 2019 Feb;15(2):115-118. doi: 10.1200/JOP.18.00536.

[Is chemotherapy still an option in oncogene-addicted non-small cell lung cancer? No].[在癌基因成瘾的非小细胞肺癌中，化疗仍是一种选择吗？不]。

Bull Cancer. 2015 Jun;102(6 Suppl 1):S96-9. doi: 10.1016/S0007-4551(15)31225-X.

Drug combination approach to overcome resistance to EGFR tyrosine kinase inhibitors in lung cancer.药物联合治疗克服肺癌中表皮生长因子受体酪氨酸激酶抑制剂耐药。

Cancer Lett. 2017 Oct 1;405:100-110. doi: 10.1016/j.canlet.2017.07.023. Epub 2017 Jul 31.

Combining inhibitors of ALK and ROS1 with other agents for the treatment of non-small cell lung cancer.将ALK和ROS1抑制剂与其他药物联合用于治疗非小细胞肺癌。

Clin Adv Hematol Oncol. 2015 May;13(5):282-4.

Challenges in ALK inhibition of ALK-positive non-small-cell lung cancer: from ALK positivity detection to treatment strategies after relapse.ALK 阳性非小细胞肺癌中 ALK 抑制的挑战：从 ALK 阳性检测到复发后的治疗策略。

Future Oncol. 2018 Sep;14(22):2303-2317. doi: 10.2217/fon-2018-0066. Epub 2018 Aug 8.

Current mechanism of acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitors and updated therapy strategies in human nonsmall cell lung cancer.人非小细胞肺癌中表皮生长因子受体-酪氨酸激酶抑制剂获得性耐药的当前机制及更新的治疗策略

J Cancer Res Ther. 2016 Dec;12(Supplement):C131-C137. doi: 10.4103/0973-1482.200613.

The immune profile of EGFR-mutated non-small-cell lung cancer at disease onset and progression after tyrosine kinase inhibitors therapy.表皮生长因子受体（EGFR）突变的非小细胞肺癌在疾病初发时及酪氨酸激酶抑制剂治疗后的进展期的免疫特征

Immunotherapy. 2018 Sep;10(12):1041-1045. doi: 10.2217/imt-2018-0027.

引用本文的文献

The role of host response to chemotherapy: resistance, metastasis and clinical implications.宿主对化疗的反应作用：耐药性、转移和临床意义。

Clin Exp Metastasis. 2024 Aug;41(4):495-507. doi: 10.1007/s10585-023-10243-5. Epub 2023 Nov 24.

本文引用的文献

Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma.组蛋白去甲基化的药理学抑制作为小儿脑干胶质瘤的一种治疗方法。

Nat Med. 2014 Dec;20(12):1394-6. doi: 10.1038/nm.3716. Epub 2014 Nov 17.

Patient-derived models of acquired resistance can identify effective drug combinations for cancer.患者来源的获得性耐药模型可识别出针对癌症的有效联合用药方案。

Science. 2014 Dec 19;346(6216):1480-6. doi: 10.1126/science.1254721. Epub 2014 Nov 13.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验